These studies demonstrated the tumor-inhibiting role of activated Notch1 in CAFs in the context of melanoma and lung cancer, thus providing an important therapeutic avenue by utilizing and inducing NOTCH1. This evidence concerns the gene NOTCH1 and lung carcinoma.